Levamisole and the treatment of Herpesvirus hominis infections. A case report

Abstract

The successful treatment with levamisole of 3 categories of Herpesvirus hominis infection is described. A fourth category of patients infected with vulval condylomata acuminata were unsuccessfully treated with levamisole. The dosage regimen is discussed. The most dramatic feature was the relief of the severe pain encountered in the acute cases. Levamisole has also prevented further attacks to date. There is no doubt that levamisole has a definite place in the treatment of H. hominis infections.